|
Vol. 34 Nş 5 |
Lat. Am. J. Pharm. 34 (5): 849-1060 (2015) |
REGULAR ARTICLES |
 |
|
Studies on Polymeric and Lipid Nanoparticles of Ketoconazole for Ocular Administration *
DEMİREL M. & GENÇ L. (853)
|
|
|
|
Simultaneous Determination of Astragaloside-IV and Triptolide of Xinfeng Capsule in Rat Plasma by LC-MS/MS: Application to Pharmacokinetic Study *
WANG W. HU S., WU H., LIU J., CHEN J., CHEN J., DAI M., SUN L., WANG R. & LI S. (862)
|
|
|
|
Pregnant Women's Awareness and Perception about Medicines *
ELDALO A.S., SIRAJ N. & MA Y. (869)
|
|
|
|
Determination of Captopril in Plasma by High-Performance Liquid Chromatography: Application in an In-Vivo Evaluation of Drug Release from Hydrogel *
IQBAL F.M., AHMAD M., ZUBAIR M.M., TULAIN U.R. & RASHID A. (875)
|
|
|
|
Application of a Mixture Experimental Design in the Optimization of the Formulation of Solid Self-Emulsifying Drug Delivery Systems Containing Carbamazepine *
KRSTIĆ M.Z., RAIĆ S.S., DJEKIĆ L.M., DOBRIČIĆ V.D., MOMČILOVIĆ M.A., VASILJEVIĆ D.D. & IBRIĆ S.R. (885)
|
|
|
|
An HPLC method for the Determination of Penciclovir in Human Plasma *
LIU W., LU G., XU Z., LI W., SHAO J., & WANG X. (895)
|
|
|
|
Pharmacovigilance Study: Exploring the Role of Community Pharmacists in Adverse Drug Reactions Reporting in Alkharj City, Saudi Arabia *
RABBA A.K. & AIN M.R. (901)
|
|
|
|
A Novel Ointment to Treat Donor Sites in Scald Mouse *
FENG W., ZHAO T., MAO G., ZOU Y., ZHENG D., WANG W., ZHENG W., ZHU Y., GU X., YANG L. & WU X. (907)
|
|
|
|
Design, Evaluation and Radiographic Study of a Novel Floating Film Bearing Famotidine as a Model Drug *
GUPTA R., PRAJAPATI S.K., PATTNAIK S. & BHARDWAJ P. (917)
|
|
|
|
Synthesis, Docking, Metal Chelating and Biological Activity of New Oxalamide Analogues for Alzheimer Disease *
KASAP Z., YERDELEN K., KOCA M. & ANİL B. (924)
|
|
|
|
Determination of Leflunomide in Tablets by Micellar Electrokinetic Capillary Chromatography *
REÇBER T. & KIR S. (934)
|
|
|
|
Stability and Compatibility of Fleroxacin for Intravenous Infusion in Xylitol Injection or Fructose Injection *
XIONG J., YE H., FAN L., YANG J. & CHEN L. (941)
|
|
|
|
Development and Analysis of Risedronate Sodium Loaded Multi-particulate Drug Delivery Syste Using Superabsorbent Co-polymer *
SHAHZAD M.K., MURTAZA G., HUSSAIN T. & KARIM S. (948)
|
|
|
|
Initial-Rate and Fixed-Time Kinetic Spectrophotometric Methods for Determination of Gatifloxacin in Bulk and Tablets *
DARWISH I.A., ASKAL H.F., REFAAT I.H. & MARZOUQ M.A. (958)
|
|
|
|
Effects of Food on the Pharmacokinetics of Tribendimidine Enteric-Coated Tablet in Healthy Chinese Subjects *
YUAN G., ZHANG R., WEI C., LI R., WANG B., LI W. & GUO R. (967)
|
|
|
|
The Comparison of Resveratrol and N-Acetylcysteine on the Oxidative Kidney Damage Caused by High Dose Paracetamol *
YAPANOGLU T., ADANUR S., ZIYPAK T., ARSLAN A., KUNAK C.S.., ALP H.H. & SULEYMAN B. (973)
|
|
|
|
Determination of Erlotinib in Rat Plasma by HPLC and Application to a Pharmacokinetic Study *
HOU Y., WEI L., ZHANG D., ZHANG J. & YANG D. (980)
|
|
|
|
Formulation and In Vitro Characterization of Huperzine A Loaded Zein Microspheres as a Sustained Delivery System for the Treatment of Alzheimer's Disease *
YU J., GAO Q., LIU H., YANG L., WU J. & DING P. (985)
|
|
|
|
Effect of Chrysin on the Apoptosis and Protein Kinase B (AKT) Pathway in Caov-3 Cell Line *
WANG Y., WEI Z., WANG X., DING Z., GUO C. & TENG D. (993)
|
|
|
|
Synthesis, BSA Interaction and Antimicrobial Activities of Two Amantadine Schiff Bases *
MA P., LIU Y., ZHANG L., ZHANG J., LIU B., LIU B. & KONG Y. (999)
|
|
|
|
Modeling and Comparison of Dissolution Profiles of Diltiazem HCl Sustained Release Formulations *
QAZI F., SHOAIB M.H., YOUSUF R.I., MEHMOOD Z.A., ZAFAR S. & BANO N. (1006)
|
|
|
|
Pharmacokinetic Study of Tramadol in Rat by Liquid Chromatography Mass Spectrometry *
LIN K., LIU Z., YANG S., LIN Y., WEN C., WANG Z. & CHEN C. (1016)
|
|
|
|
Transdermal Diclofenac Potassium Gels: Natural Penetration Enhancers, Can Be Effective? *
HUSSAIN A., KHAN G.M., KHAN N.R., KHAN A. & ASIF M. (1022)
|
|
|
SHORT COMMUNICATIONS |
 |
|
Cerebral Haemorrhage Treatment Drug Bruceine A is a Strong Inhibitor of Cytochrome P450 (CYP) 3A4 *
WANG T., LIU Y., LI H., NING F., LIANG Y. & BI J. (1030)
|
|
|
|
Metabolomics Analysis of Lasiodin-Related Potential Drug-Drug Interaction and Clinical Therapy of Lasiodin towards Nasopharyngeal Carcinoma *
WANG C., LIU S., PENG J., TANG C., & ZHU W. (1033)
|
|
|
|
Drug-Drug Interaction and Therapeutic Mechanism of Doxetaxel towards Clinical Breast Cancer Patients *
ZHANG J., SUN J., HUAI D., ZHAO Z., HAN X., SHI J., TANG J., ZHEN L., WANG W., YAN X., ZHAO Z. & DAI J. (1036)
|
|
|
|
Pentamidine-Loaded Poly(e-Caprolactone) Nanoparticles Show Low Acute Lung Toxicity In Vivo *
FERREIRA L.M., CERVI V.F., PEGORARO N.S., BARBIERI A.V., ALANO G., GIRONDI N.G., PIRES C.C., FRITZEN L.M., TASSO L. & CRUZ L. (1039)
|
|
|
|
Metabolism Difference of Schisanhenol in the Liver under the Different Liver Diseases *
HOU J., JIN X., WU L., WU S., LUO D. & MA M. (1043)
|
|
|
|
Bioinformatics-Guided In Vitro Method to Demonstrate the Inhibition of Cardiovascular Drug (R)-Rivaroxaban towards Cytochrome P450 (CYP) 3A4 *
SHI P., LI L. & BAI Z. (1047)
|
|
|
|
Mastic Acid Exhibits Strong Inhibition Potential towards Drug-Metabolizing Enzymes Involved in the Metabolism of Cardiovascular Therapeutic Drugs *
YANG H., KONG L. & YU F. (1051)
|
|
|
|
Lapatinib-Related Drug Utilization Risk and Therapeutics towards Clinical Esophageal Cancer *
PU J., PENG J., ZHU W., & WANG W. (1055)
|
|
|
_________________
* English
** Portugûes
|
 |
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|